268 related articles for article (PubMed ID: 25229616)
1. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
So JY; Lin JJ; Wahler J; Liby KT; Sporn MB; Suh N
PLoS One; 2014; 9(9):e107616. PubMed ID: 25229616
[TBL] [Abstract][Full Text] [Related]
2. CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells.
Kim EH; Deng CX; Sporn MB; Liby KT
Cancer Prev Res (Phila); 2011 Mar; 4(3):425-34. PubMed ID: 21372041
[TBL] [Abstract][Full Text] [Related]
3. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
Ji Y; Lee HJ; Goodman C; Uskokovic M; Liby K; Sporn M; Suh N
Mol Cancer Ther; 2006 Jun; 5(6):1452-8. PubMed ID: 16818503
[TBL] [Abstract][Full Text] [Related]
4. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
[TBL] [Abstract][Full Text] [Related]
5. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
Place AE; Suh N; Williams CR; Risingsong R; Honda T; Honda Y; Gribble GW; Leesnitzer LM; Stimmel JB; Willson TM; Rosen E; Sporn MB
Clin Cancer Res; 2003 Jul; 9(7):2798-806. PubMed ID: 12855660
[TBL] [Abstract][Full Text] [Related]
6. The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor beta-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complex.
To C; Kulkarni S; Pawson T; Honda T; Gribble GW; Sporn MB; Wrana JL; Di Guglielmo GM
J Biol Chem; 2008 Apr; 283(17):11700-13. PubMed ID: 18283107
[TBL] [Abstract][Full Text] [Related]
7. High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide.
Petronelli A; Saulle E; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Greggi S; Cognetti F; Russo MA; Sporn M; Testa U
Cancer Lett; 2009 Sep; 282(2):214-28. PubMed ID: 19364626
[TBL] [Abstract][Full Text] [Related]
8. Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid.
Ikeda T; Nakata Y; Kimura F; Sato K; Anderson K; Motoyoshi K; Sporn M; Kufe D
Mol Cancer Ther; 2004 Jan; 3(1):39-45. PubMed ID: 14749474
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition and apoptosis of human multiple myeloma cells induced by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid derivatives.
Rogers LJ; John T; Park J; Tucker M; Ma H; Wu Y; Rayalam S; Wang X
Anticancer Drugs; 2020 Sep; 31(8):806-818. PubMed ID: 32304407
[TBL] [Abstract][Full Text] [Related]
10. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
[TBL] [Abstract][Full Text] [Related]
11. The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.
Hughes DT; Martel PM; Kinlaw WB; Eisenberg BL
Cancer Invest; 2008 Mar; 26(2):118-27. PubMed ID: 18259941
[TBL] [Abstract][Full Text] [Related]
12. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
Ding T; Yang LJ; Zhang WD; Shen YH
J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
14. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
[TBL] [Abstract][Full Text] [Related]
15. 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer.
Samudio I; Konopleva M; Hail N; Shi YX; McQueen T; Hsu T; Evans R; Honda T; Gribble GW; Sporn M; Gilbert HF; Safe S; Andreeff M
J Biol Chem; 2005 Oct; 280(43):36273-82. PubMed ID: 16118208
[TBL] [Abstract][Full Text] [Related]
16. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
[TBL] [Abstract][Full Text] [Related]
17. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
[TBL] [Abstract][Full Text] [Related]
18. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J
Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607
[TBL] [Abstract][Full Text] [Related]
19. Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.
Riccioni R; Senese M; Diverio D; Riti V; Mariani G; Boe A; LoCoco F; Foà R; Peschle C; Sporn M; Testa U
Leuk Res; 2008 Aug; 32(8):1244-58. PubMed ID: 18304628
[TBL] [Abstract][Full Text] [Related]
20. The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.
Townson JL; Macdonald IC; Liby KT; Mackenzie L; Dales DW; Hedley BD; Foster PJ; Sporn MB; Chambers AF
Clin Exp Metastasis; 2011 Mar; 28(3):309-17. PubMed ID: 21234655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
